1Kessler RC , McGonagle KA , Zhao S, et al. Lifetime and 12-month prevalence of DSM-Ⅲ-R psychiatric disorders in the U-nited States: results from the national comorbidity Survey[J]. Arch Gen Psychiatry,1994, 51:8-19.
3Ballenger JC . Overview of different pharmaeotherapies for attaining remission in generalized anxiety disorder [J]. J Clin Psychiatry, 2001,62(suppl 19) :11-19.
4DeVane CL.Immediate-release versus controlled-release formulations : pharmacokinetics of newer antidepressants in relation to nausea [J]. J Clin Psychiatry, 2003,64 (suppl 18):14-19.
5Rickels K ,Pollack MH ,Sheehan DV, et al: Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder[J]. Am J Psychiatry, 2000,157:968-974.
6Allgulander C,Hackett D , Salinas E .Venlafaxine extended re-lease(ER) in the treatment of generalised anxiety disorder [J]. Br J Psychiatry,2001,179:15-22.
7Khan A, Khan S , Kolts R,et al. Suicide rate in clinical trials of SSRIS , other antidepressants , and placebo: analysis of FDA re-ports [J]. Am J Psychiatry, 2003,160:790-792.
4Paykel E, Bamana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psycho Med,1995,25 : 1171-1180.
5Thase ME, Entsuah AR, Rvdolph RL,et al. Remission rates during treatment with venlafaxine or SSRIs. Br J Psychiatry,2001,178:234-241.
6Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry, 2000,57:503-509.
7Feighner JP. Overview of antidepressants currently used to treat anxiety disorders. J Clin Psychiatry, 1999,60 Suppl 2:18-22.
8Ballus C, Quiros G, De Flores T, et al. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive or dysthymia, Int Clin Psychopharmacol, 2000, 15: 43-48.
9Mehetonen OP, Belinke K, Sogaard J,et al. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depression. J CAin Psychialry,2000, 61:95-100.
10Poirer MF, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression: double-blind, randomized comparison. Br J Psychiatry,1999, 175:12-16.
7Fu Cui. Metacognitive models: generalized anxiety disorder in the research of new ideas [ J ]. Medicine and Philosophy, 2001,12 ( 12 ) : 134 - 137.
8Zheng Ya Ke, even the runner-up. Venlafaxine and paroxetine in the treatment of comorbid anxiety or depression of tension type headache clinical research [J]. The Chinese Journal of Pain Medicine,2009,8 (6) :11 - 15.
9Yang Jiadan, Ouyang Jing. Venlafaxine and fluoxetine in the treatment of depression curative effect comparison of Meta analysis [J]. China Journal of Nervous and Mental Diseases,2009,9 ( 1 ) :45 - 49.
